Biomedical Engineering Reference
In-Depth Information
[101]
Baxter MA, C Rowe, J Alder, S Harrison, KP Hanley, BK Park, NR Kitteringham, CE
Goldring and NA Hanley (2010). Generating hepatic cell lineages from pluripotent stem cells
for drug toxicity screening. Stem cell research 5: 4-22.
[102]
Bone HK, AS Nelson, CE Goldring, D Tosh and MJ Welham (2011). A novel chemically
directed route for the generation of definitive endoderm from human embryonic stem cells
based on inhibition of GSK-3. Journal of Cell Science 124: 1992-2000.
[103]
Kehat I, D Kenyagin-Karsenti, M Snir, H Segev, M Amit, A Gepstein, E Livne, O Binah,
J Itskovitz-Eldor and L Gepstein (2001). Human embryonic stem cells can differentiate into myo-
cytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation
108: 407-414.
[104]
Schuldiner M and N Benvenisty (2003). Factors controlling human embryonic stem cell
differentiation. Methods in Enzymology 365: 446-461.
[105]
Spence JR, CN Mayhew, SA Rankin, MF Kuhar, JE Vallance, K Tolle, EE Hoskins, VV
Kalinichenko, SI Wells and AM Zorn (2010). Directed differentiation of human pluripotent
stem cells into intestinal tissue
in vitro
. Nature 470: 105-109.
[106]
Petit I, M Szyper-Kravitz, A Nagler, M Lahav, A Peled, L Habler, T Ponomaryov, RS Taichman,
F Arenzana-Seisdedos and N Fujii (2002). G-CSF induces stem cell mobilization by decreasing
bone marrow SDF-1 and up-regulating CXCR4. Nature Immunology 3: 687-694.
[107]
Lévesque J-P, J Hendy, IG Winkler, Y Takamatsu and PJ Simmons (2003). Granulocyte
colony-stimulating factor induces the release in the bone marrow of proteases that cleave
c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Experimental
Hematology 31: 109-117.
[108]
Ehnert S, M Glanemann, A Schmitt, S Vogt, N Shanny, NC Nussler, U Stöckle and A Nussler
(2009). The possible use of stem cells in regenerative medicine: dream or reality? Langenbeck's
Archives of Surgery 394: 985-997.
[109]
Ebrahimian T, F Pouzoulet, C Squiban, V Buard, M André, B Cousin, P Gourmelon,
M Benderitter, L Casteilla and R Tamarat (2009). Cell therapy based on adipose tissue-derived
stromal cells promotes physiological and pathological wound healing. Arteriosclerosis,
Thrombosis, and Vascular Biology 29: 503-510.
[110]
François S, M Mouiseddine, N Mathieu, A Semont, P Monti, N Dudoignon, A Saché,
A Boutarfa, D Thierry and P Gourmelon (2007). Human mesenchymal stem cells favour
healing of the cutaneous radiation syndrome in a xenogenic transplant model. Annals of
hematology 86: 1-8.
[111]
Stephenson E, CM Ogilvie, H Patel, G Cornwell, L Jacquet, N Kadeva, P Braude and D Ilic
(2010). Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells.
Journal of The Royal Society Interface 7: S677-S688.
[112]
Hidaka M, GN-C Su, JK-H Chen, K-i Mukaisho, T Hattori and G Yamamoto (2007).
Transplantation of engineered bone tissue using a rotary three-dimensional culture system. In
vitro Cellular and Developmental Biology - Animal 43: 49-58.
[113]
He L, X Nan, Y Wang, L Guan, C Bai, S Shi, H Yuan, L Chen, D Liu and X Pei (2007). Full-
thickness tissue engineered skin constructed with autogenic bone marrow mesenchymal stem
cells. Science in China Series C: Life Sciences 50: 429-437.
[114]
Goldring CE, PA Duffy, N Benvenisty, PW Andrews, U Ben-David, R Eakins, N French, NA
Hanley, L Kelly and NR Kitteringham (2011). Assessing the safety of stem cell therapeutics.
Cell Stem Cell 8: 618-628.
[115]
Ben-David U and N Benvenisty (2011). The tumorigenicity of human embryonic and induced
pluripotent stem cells. Nature Reviews Cancer 11: 268-277.
[116]
Blum B and N Benvenisty (2008). The tumorigenicity of human embryonic stem cells. Advances
in Cancer Research 100: 133-158.
[117]
Drukker M and N Benvenisty (2004). The immunogenicity of human embryonic stem-derived
cells. Trends in Biotechnology 22: 136-141.
[118]
Swijnenburg R-J, S Schrepfer, JA Govaert, F Cao, K Ransohoff, AY Sheikh, M Haddad,
AJ Connolly, MM Davis and RC Robbins (2008). Immunosuppressive therapy mitigates
immunological rejection of human embryonic stem cell xenografts. Proceedings of the National
Academy of Sciences 105: 12991-12996.
